Clinical Trial Update: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by PT. Prodia Stem Cell Indonesia is evaluating mesenchymal stem cells and MSC-conditioned medium as adjuvant therapy for A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• MSC-conditioned Medium (MSC-conditioned medium)
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: RECRUITING